Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound-Reference-Cited by-同舟云学术

Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound

Published:2017-05-03 Issue:1 Volume:58 Page:215-230
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Baazaoui Narjes¹²,Iqbal Khalid¹

Affiliation:

1. Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA

2. Graduate Program in Biology (Neuroscience), College of Staten Island, City University of New York Graduate Center, New York, NY, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference55 articles.

1. Memory loss in Alzheimer’s disease;Jahn;Dialogues Clin Neurosci,2013

2. Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein;Glenner;Biochem Biophys Res Commun,1984

3. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology;Grundke-Iqbal;Proc Natl Acad Sci U S A,1986

4. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease;Gómez-Isla;Ann Neurol,1997

5. Synapse loss in frontal cortex biopsies in Alzheimer’s disease: Correlation with cognitive severity;DeKosky;Ann Neurol,1990

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau and Alzheimer's disease: Past, present and future;Cytoskeleton;2023-12-21

2. Targeting NLRP3 inflammasome for neurodegenerative disorders;Molecular Psychiatry;2023-09-05

3. The development of peptide- and oligonucleotide-based drugs to prevent the formation of abnormal tau in tauopathies;Expert Opinion on Drug Discovery;2023-04-11

4. Alzheimer’s Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound;Biomolecules;2022-10-02

5. The synapse as a treatment avenue for Alzheimer’s Disease;Molecular Psychiatry;2022-04-20